DUBLIN, May 6, 2020 /PRNewswire/ -- The "Lung Marker Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
The global lung marker market grew at a CAGR of around 8% during 2014-2019. Looking forward, the market is projected to continue its strong growth during the next five years.
The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers.
Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level.
Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.
The competitive landscape of the industry has also been examined with some of the key players being Abbott Diagnostics Ltd., Affymetrix Inc., Agilent Technologies Inc., Beckman Coulter, Fujirebio US, Hologic Inc., Roche, Siemens Healthineers, Thermo Fisher Scientific., Veridex LLC, etc.
Key Questions Answered
- How has the global lung marker market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What is the breakup of the market based on the cancer type?
- What is the breakup of the market based on the marker type?
- What is the breakup of the market based on the end user?
- What are the key driving factors and challenges in the market?
- What is the structure of the global lung marker market and who are the key players?
- What is the degree of competition in the market?
Key Topics Covered
2 Scope and Methodology
3 Executive Summary
4.2 Key Industry Trends
5 Global Lung Marker Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast
6 Market Breakup by Cancer Type
6.1 Non-Small Cell Lung Cancer (NSCLC)
6.2 Small Cell Lung Cancer (SCLC)
7 Market Breakup by Marker Type
8 Market Breakup by End User
8.2 Diagnostic Labs
9 Market Breakup by Region
9.1 North America
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East and Africa
10 SWOT Analysis
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- Abbott Diagnostics Ltd.
- Affymetrix Inc.
- Agilent Technologies Inc.
- Beckman Coulter
- Fujirebio US
- Hologic Inc.
- Siemens Healthineers
- Thermo Fisher Scientific.
- Veridex LLC
For more information about this report visit https://www.researchandmarkets.com/r/u17xo6
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets